PriceTargets.com logo

Bright Health Group - BHG Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00%
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$3.82 As of 12/20/2024 01:00 AM ET
▼ -0.13 (-3.29%)

This chart shows the closing price for BHG by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Bright Health Group Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for BHG and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for BHG

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for Bright Health Group in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $3.82.

This chart shows the closing price for BHG for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is N/A

The current consensus among 0 polled investment analysts is to n/a stock in Bright Health Group. This rating has held steady since May 2024, when it changed from a Sell consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 3 sell ratings
Ratings as of
6/29/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 3 sell ratings
Ratings as of
9/27/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 1 sell ratings
Ratings as of
12/26/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 1 sell ratings
Ratings as of
3/25/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/23/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/21/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/20/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/20/2024

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
6/15/2023BarclaysDowngradeOverweight ➝ Underweight
5/30/2023Royal Bank of CanadaLower Target$80.00 ➝ $13.00
12/13/2022The Goldman Sachs GroupDowngradeNeutral ➝ Sell
11/16/2022CowenLower Target$80.00
11/16/2022CitigroupLower TargetNeutral$180.00 ➝ $96.00
10/11/2022JPMorgan Chase & Co.DowngradeNeutral ➝ Underweight
8/22/2022CowenLower Target$160.00
8/11/2022Piper SandlerLower TargetOverweight$400.00 ➝ $240.00
3/29/2022JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral$160.00
3/4/2022Royal Bank of CanadaDowngradeOutperform ➝ Sector Perform$720.00 ➝ $240.00
3/3/2022The Goldman Sachs GroupLower TargetNeutral$400.00 ➝ $280.00
3/3/2022Morgan StanleyLower TargetUnderweight$320.00 ➝ $160.00
3/3/2022CowenLower Target$480.00 ➝ $240.00
3/3/2022BarclaysLower TargetOverweight$440.00 ➝ $320.00
3/3/2022Piper SandlerLower TargetOverweight$800.00 ➝ $400.00
3/2/2022Bank of AmericaDowngradeBuy ➝ Underperform
1/7/2022BarclaysLower TargetOverweight ➝ Overweight$720.00 ➝ $440.00
12/16/2021Morgan StanleyDowngradeEqual Weight ➝ Underweight$400.00 ➝ $320.00
12/14/2021The Goldman Sachs GroupInitiated CoverageNeutral$400.00
12/10/2021JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight$480.00
11/12/2021Piper SandlerLower TargetOverweight$1,920.00 ➝ $800.00
11/12/2021Royal Bank of CanadaLower TargetOutperform$1,760.00 ➝ $720.00
11/12/2021Morgan StanleyDowngradeOverweight ➝ Equal Weight$1,040.00 ➝ $400.00
11/10/2021BarclaysLower TargetOverweight$1,360.00 ➝ $960.00
11/2/2021CowenDowngradeOutperform ➝ Market Perform$1,120.00 ➝ $720.00
11/1/2021CitigroupDowngradeBuy ➝ Neutral$800.00
9/9/2021CowenInitiated CoverageOutperform$1,120.00
8/31/2021Morgan StanleyBoost TargetOverweight$960.00 ➝ $1,040.00
8/4/2021Morgan StanleyUpgradeEqual Weight ➝ Overweight$1,440.00 ➝ $960.00
8/4/2021CitigroupUpgradeNeutral ➝ Buy$1,280.00 ➝ $960.00
7/19/2021Bank of AmericaInitiated CoverageBuy$1,920.00
7/19/2021JPMorgan Chase & Co.Initiated CoverageNeutral$1,520.00
7/19/2021Morgan StanleyInitiated CoverageEqual Weight$1,440.00
7/19/2021Wolfe ResearchInitiated CoveragePeer Perform$1,200.00
7/19/2021CitigroupInitiated CoverageNeutral$1,280.00
7/19/2021Royal Bank of CanadaInitiated CoverageOutperform$1,760.00
7/19/2021The Goldman Sachs GroupInitiated CoverageBuy
7/19/2021Piper SandlerInitiated CoverageOverweight$1,920.00
(Data available from 12/21/2019 forward)

News Sentiment Rating

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/25/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/24/2024
  • 1 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/24/2024
  • 0 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/23/2024
  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/22/2024
  • 0 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/22/2024
  • 1 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/21/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/21/2024

Current Sentiment

  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

  • No positive mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
Bright Health Group logo
Bright Health Group, Inc., a healthcare company, provides health insurance policies in the United States. It operates in two segments, Bright HealthCare and Consumer Care. The Consumer Care segment delivers virtual and in-person clinical care services contracts through primary care clinics. It operates managed and affiliated risk-bearing clinics within its integrated care delivery system, which included embedded pharmacy, laboratory, radiology, and population health focused specialty services. The Bright HealthCare segment offers medicare health plan products to consumers. The company was formerly known as Bright Health Inc. and changed its name to Bright Health Group, Inc. in February 2021. Bright Health Group, Inc. was incorporated in 2015 and is headquartered in Minneapolis, Minnesota.
Read More

Today's Range

Now: $3.82
Low: $3.79
High: $3.96

50 Day Range

MA: $5.31
Low: $3.95
High: $16.35

52 Week Range

Now: $3.82
Low: $4.94
High: $82.40

Volume

13,459 shs

Average Volume

72,717 shs

Market Capitalization

$30.49 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.93

Frequently Asked Questions

What sell-side analysts currently cover shares of Bright Health Group?

The following Wall Street sell-side analysts have issued stock ratings on Bright Health Group in the last twelve months:
View the latest analyst ratings for BHG.

What is the current price target for Bright Health Group?

0 Wall Street analysts have set twelve-month price targets for Bright Health Group in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Bright Health Group in the next year.
View the latest price targets for BHG.

What is the current consensus analyst rating for Bright Health Group?

Bright Health Group currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for BHG.

What other companies compete with Bright Health Group?

Other companies that are similar to Bright Health Group include NeueHealth, UnitedHealth Group, Elevance Health, The Cigna Group and Humana. Learn More about companies similar to Bright Health Group.

How do I contact Bright Health Group's investor relations team?

The company's listed phone number is 612-238-1321 and its investor relations email address is [email protected]. The official website for Bright Health Group is www.brighthealthcare.com. Learn More about contacing Bright Health Group investor relations.